RICHMOND, Va.--(BUSINESS WIRE)--Jan. 24, 2002--Insmed Incorporated (Nasdaq:INSM) will announce financial results for its 2001 fiscal year and fiscal fourth quarter approximately 4:00 p.m. EST on...
RICHMOND, Va., Jan 8, 2002 (BW HealthWire) -- Insmed Incorporated (Nasdaq: INSM) announced today positive results from a Phase II dose-ranging trial of SomatoKine® in patients with type 2...
RICHMOND, Va., Jan 03, 2002 (BW HealthWire) -- Insmed Incorporated (NASDAQ: INSM) announced today the appointment of Fredrick L. Dunn, M.D., formerly of Novartis Pharmaceuticals Corp., as Vice...
Insmed Incorporated © 2021 All rights reserved.
Insmed Incorporated © 2021 All rights reserved.
Insmed, ARIKAYCE, Arikares, and PULMOVANCE are trademarks of Insmed Incorporated. All other trademarks are property of their respective owner.
© Insmed 2021 All Rights Reserved.Terms of UsePrivacy Policy